A carregar...
New Oral Anticoagulants in Nonvalvular Atrial Fibrillation
The choice of an oral anticoagulant (OAC) for patients with nonvalvular atrial fibrillation (NVAF) is a major and complex clinical decision taking into account the individual risk‐benefit ratio and bearing in mind the chronicity of therapy. This review focuses on the safety and efficacy of new oral...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6490750/ https://ncbi.nlm.nih.gov/pubmed/27716952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22582 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|